223526-84-9

Basic information

• Product Name: methyl 5-bromo-2-{[(4-methylphenyl)sulfonyl]amino}benzoate
• Synonyms: methyl 5-bromo-2-{[(4-methylphenyl)sulfonyl]amino}benzoate;methyl 5-bromo-2-(4-methylphenylsulfonamido)benzoate
• CAS NO: 223526-84-9
• Molecular Formula: C₁₅H₁₄BrNO₄S
• Molecular Weight: 384.24496
• Mol File: 223526-84-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 5-bromo-2-{[(4-methylphenyl)sulfonyl]amino}benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-bromo-2-{[(4-methylphenyl)sulfonyl]amino}benzoate(223526-84-9)
• EPA Substance Registry System: methyl 5-bromo-2-{[(4-methylphenyl)sulfonyl]amino}benzoate(223526-84-9)

Safety Data

• Hazardous Substances Data: 223526-84-9(Hazardous Substances Data)

Upstream product

• 134-20-3 2-carbomethoxyaniline 
• 98-59-9 p-toluenesulfonyl chloride 
• 50998-74-8 methyl N-tosylanthranilate 
• 52727-57-8 5-bromo-2-aminobenzoic acid methyl ester 

Downstream Products

• 943819-81-6 methyl 5-bromo-2-{(4-methoxy-4-oxobutyl)[(4-methylphenyl)sulfonyl]amino}benzoate 
• 34159-05-2 N-(4-bromo-2-formylphenyl)-4-methylbenzenesulfonamide 
• 223526-94-1 methyl 5-bromo-2-(2-propenyl-4-toluenesulfonylamino)benzoate 
• 223526-95-2 N-(5-bromo-2-hydroxymethylphenyl)-N-(2-propenyl)-4-toluenesulfonylamide 
• 223526-85-0 N-(5-bromo-2-formylphenyl)-N-(2-propenyl)-4-toluenesulfonylamide 
• 739355-72-7 7-{4-[2-(butoxy)ethoxy]phenyl}-1-cyclobutylmethyl-N-(4-{[methyl(tetrahydro-2H-pyran-4-yl)amino]methyl}phenyl)-2,3-dihydro-1H-1-benzazepine-4-carboxamide 

Relevant articles and documents

Preparation of a 1-unsubstituted-2,3-dihydro-1-benzazepine derivative

We developed a three-step method of producing a 1-unsubstituted-2,3-dihydro-1-benzazepine derivative (2) from 11. The alkylation of 9, obtained from 11, and the subsequent intramolecular condensation of 12 in dialkyl carbonate with a metal alcoholate were

BENZAZEPINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF

Compounds of the general formula (I): or salts thereof, which exhibit CCR5 antagonism and exert preventive and therapeutic effects against HIV infections: wherein R1 is a 5- to 6-membered aromatic ring which bears a substituent represented by the general formula: R-Z1-X-Z2- (wherein R1 is hydrogen or optionally substituted hydrocarbyl; X is optionally substituted alkylene; and Z1 and Z2 are each a heteroatom) and may be further substituted, with R being optionally bonded to the aromatic ring to form another ring; Y is optionally substituted imino; and R2 and R3 are each optionally substituted aliphatic hydrocarbyl or an optionally substituted hetero-alicyclic group.

An approach to the pyrroloquinoline core of martinelline and martinellic acid

An expedient method for the assembly of the pyrroloquinoline skeleton found in the martinelline alkaloids using a [3+2] cycloaddition of an azomethine ylide and an alkene has been developed.